Mastrapasqua Asset Management’s Guardant Health GH Stock Holding History

Mastrapasqua Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,098	Closed	-$1.11M	–	147
2021 Q4	$1.11M	Sell	11,098 -514	-4%	-$53.2K	0.11%	117
2021 Q3	$1.45M	Sell	11,612 -108	-0.9%	-$12.8K	0.16%	101
2021 Q2	$1.46M	Buy	11,720 +215	+2%	+$28.9K	0.15%	110
2021 Q1	$1.76M	Buy	11,505 +1,096	+11%	+$166K	0.21%	91
2020 Q4	$1.34M	Sell	10,409 -733	-7%	-$84.3K	0.18%	93
2020 Q3	$1.25M	Buy	11,142 +225	+2%	+$20.6K	0.17%	97
2020 Q2	$886K	Buy	10,917 +145	+1%	+$11.7K	0.14%	104
2020 Q1	$750K	Sell	10,772 -2,373	-18%	-$182K	0.15%	99
2019 Q4	$1.03M	Sell	13,145 -95	-0.7%	-$6.85K	0.17%	98
2019 Q3	$845K	Buy	13,240 +670	+5%	+$59K	0.16%	99
2019 Q2	$1.08M	Buy	+12,570	New	+$960K	0.21%	91

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mastrapasqua Asset Management's GH Position: Q1 2022 in Review

Mastrapasqua Asset Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 11,098 shares — an estimated $1.11M sold.

Mastrapasqua Asset Management first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $1.76M in Q1 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Mastrapasqua Asset Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Mastrapasqua Asset Management sold 11,098 Guardant Health shares in Q1 2022, an estimated $1.11M.
Mastrapasqua Asset Management first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
Mastrapasqua Asset Management's Guardant Health position peaked at $1.76M in Q1 2021.
355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Mastrapasqua Asset Management's 13F filing for Q1 2022, filed 21 Apr 2022.